Results 171 to 180 of about 45,109 (224)
Immune microenvironment of infantile hemangioma: cellular dynamics, molecular networks, and emerging immunomodulatory strategies. [PDF]
Yang L +6 more
europepmc +1 more source
Cholinergic and noradrenergic modulation of perceptual decision making and learning
Dias Maile AA +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Radioimmunoassay of propranolol
Analytical Chemistry, 1983A series of specific antibodies against d,I-propranolol has been developed by conjugation of the novel 5'-, 7'-, and 8'-(3-aminopropoxy)propranolol derivatives to succinylated bovine serum albumin. By preservation of an intact side chain in the antigen, significantly improved specificity to parent drug vs.
T D, Eller, D R, Knapp, T, Walle
openaire +2 more sources
Pharmacokinetics of propranolol
Journal of Pharmacokinetics and Biopharmaceutics, 1981The pharmacokinetics of propranolol after the administration of 40, 80, and 120 mg p.o. and 10 mg i.v. was studied in nine healthy male volunteers. Propranolol was analyzed after extraction and derivatization by gas-liquid chromatography. A multiexponential curve-stripping program was used for the pharmacokinetic analysis.
L, Borgström +3 more
openaire +2 more sources
Journal of Pharmaceutical Sciences, 1979
Two improvements in propranolol resolution were developed. Both the (+)- and (-)-di-(p-toluoyl)tartaric acids were used as the resolving agents. This procedure reduced the number of crystallizations needed to obtain a pure product. Furthermore, synthesis of the resolving agent was improved.
Y, Yost, J L, Holtzman
openaire +2 more sources
Two improvements in propranolol resolution were developed. Both the (+)- and (-)-di-(p-toluoyl)tartaric acids were used as the resolving agents. This procedure reduced the number of crystallizations needed to obtain a pure product. Furthermore, synthesis of the resolving agent was improved.
Y, Yost, J L, Holtzman
openaire +2 more sources
Journal of Plastic Surgery and Hand Surgery, 2013
A slow-involuting segmental haemangioma was initially treated conventionally. Proliferation recurred when treatment was stopped. When the effect of propranolol on haemangiomas was published, we treated this 2.5- year- old girl with it. The haemangioma finally regressed recorded on magnetic resonance imaging and at clinical follow-up.
Engberg Damsgaard, Tine +1 more
openaire +2 more sources
A slow-involuting segmental haemangioma was initially treated conventionally. Proliferation recurred when treatment was stopped. When the effect of propranolol on haemangiomas was published, we treated this 2.5- year- old girl with it. The haemangioma finally regressed recorded on magnetic resonance imaging and at clinical follow-up.
Engberg Damsgaard, Tine +1 more
openaire +2 more sources
American Journal of Psychiatry, 1982
The authors report the cases of 3 patients who had depressive episodes after administration of propranolol for medical illnesses. The depressive episodes were severe, occurred in a dose-dependent manner, and promptly remitted when propranolol was discontinued. Physicians' awareness of this complication, especially in cases of patients with a history of
W M, Petrie, R J, Maffucci, R L, Woosley
openaire +2 more sources
The authors report the cases of 3 patients who had depressive episodes after administration of propranolol for medical illnesses. The depressive episodes were severe, occurred in a dose-dependent manner, and promptly remitted when propranolol was discontinued. Physicians' awareness of this complication, especially in cases of patients with a history of
W M, Petrie, R J, Maffucci, R L, Woosley
openaire +2 more sources
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1983
1. 15 schizophrenic patients diagnosed according to criteria of I.C.D.-9 were treated with d1-propranolol in a 4 week open study. 2. A fixed dose schedule was followed and a maximum dose of 1920 mg/day was reached by day 17. 3. Results revealed a significant reduction in core schizophrenic symptoms of CPRS & BPRS starting between 1st and second weeks ...
B B, Sethi, S, Dubé
openaire +2 more sources
1. 15 schizophrenic patients diagnosed according to criteria of I.C.D.-9 were treated with d1-propranolol in a 4 week open study. 2. A fixed dose schedule was followed and a maximum dose of 1920 mg/day was reached by day 17. 3. Results revealed a significant reduction in core schizophrenic symptoms of CPRS & BPRS starting between 1st and second weeks ...
B B, Sethi, S, Dubé
openaire +2 more sources
Clinical Pharmacology and Therapeutics, 1983
Eight hypertensive patients who had been followed in an outpatient clinic during long-term therapy with propranolol (40 to 160 mg twice daily) were studied during a 24-hr stay in the ward. The usual oral dose was given and the total and free plasma concentrations were determined during the 24 hr and the urinary excretion of unchanged drug was measured.
Andreasen, F. +4 more
openaire +3 more sources
Eight hypertensive patients who had been followed in an outpatient clinic during long-term therapy with propranolol (40 to 160 mg twice daily) were studied during a 24-hr stay in the ward. The usual oral dose was given and the total and free plasma concentrations were determined during the 24 hr and the urinary excretion of unchanged drug was measured.
Andreasen, F. +4 more
openaire +3 more sources

